Abstract:Mengqi Wang, 1, &ast Shuting Lan, 1, &ast Wenqi Zhang, 1, &ast Qin Jin, 2 Hua Du, 3 Xiaomei Sun, 1 Lijun He, 1 Xiangyun Meng, 1 Liya Su, 1 Gang Liu 1 1 Key Laboratory of Medical Cell Biology, Department of Achievement Transformation, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia, People's Republic of China; 2 Department of Pathology, Affiliated Hospital of Nantong University, Nantong, Jiangsu, People's Republic of China; 3 Department of Pathology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia, People's Republic of China &astThese authors contributed equally to this work Correspondence: Gang Liu, Email Introduction: The anti-cancer potency of copper-doped carbon quantum dots (Cu-CDs) against breast cancer progression needs more detailed investigations. Methods: With urea and ethylene glycol applied as carbon sources and copper sulfate used as a reactive dopant, Cu-CDs were synthesized in the current study by a one-step hydrothermal synthesis method, followed by the characterization and biocompatibility evaluations of Cu-CDs. Subsequently, the anti-cancer potency of Cu-CDs against breast cancer progression was confirmed by these biochemical, molecular, and transcriptomic assessments, including viability, proliferation, migration, invasion, adhesion, clonogenicity, cell cycle distribution, apoptosis, redox homeostasis, and transcriptomic assays of MDA-MB-231 cells. Results: The biocompatibility of Cu-CDs was confirmed based on the non-significant changes in the pathological and physiological parameters in the Cu-CDs treated mice, as well as the noncytotoxic effect of Cu-CDs on normal cells. Moreover, the Cu-CDs treatments not only decreased the viability, proliferation, migration, invasion, adhesion, and clonogenicity of MDA-MB-231 cells but also induced the redox imbalance, cell cycle arrest, and apoptosis of MDA-MB-231 cells via ameliorating the mitochondrial dysfunctions and regulating the MAPK signaling pathway. Conclusion: Our findings confirmed the biosafety and excellent anti-cancer potency of Cu-CDs against breast cancer progression by tapping into mechanisms that disrupt malignant behaviors and oxidative homeostasis of breast cancer cells. Keywords: copper, carbon quantum dots, breast cancer, oxidative stress, MAPK signaling pathway Breast cancer, one of the most malignant cancers with high mortality rates, is predominantly delayed due to the absence of early clinical symptoms. 1,2 Nowadays, the applications of chemotherapeutics, hormone therapy, targeted therapy, and epigenetic drugs (mainly histone deacetylases and DNA methyltransferase inhibitors) effectively promote the prognosis and clinical treatment of breast cancer patients by blocking and regulating these multiple targets and biological pathways during carcinogenesis. 3–5 However, the deteriorated relapse and metastasis in prolonged periods of clinical treatments, caused by the insufficient drug sensitivity in vivo 6–8 and toxic-side effects on cells, tissues, and organs, 9–12 seriously affect the outcome of clinical treatments and the quality of daily life for breast cancer patients. 13 Even with a mastectomy, the outcomes of breast cancer patients remain unsatisfactory due to the complex mechanism of carcinogenesis, recurrence, and metastasis in vivo. 14,15 Therefore, new therapeutic regimens and strategies for breast cancer patients are urgently needed. During the carcinogenesis, recurrence, and metastasis processes in vivo, mitochondrial dysfunction induced by the chemical depletion or overproliferation of mitochondrial DNA (mtDNA), impairment of the mitochondrial respiratory chain, pathogenic mtDNA mutations, or defects of these nuclear-encoded mitochondrial enzymes seriously promoted the malignant behaviors and invasive properties of cancer cells to an apoptosis-resistant and chemo-resistant phenotype. 16,17 The abovementioned regulation mechanisms are positively related to these various vital intracellular processes, including the regulation of immune destruction, cellular invasion, metabolic reprogramming, cellular proliferation, chronic inflammations, death resistance, induced angiogenesis, or replicative immortalities. 18–22 Moreover, the alterations in oncogenes or tumor suppressors such as tumor suppressor p53 (TP53) or hypoxia-inducible factor 1 (HIF-1) also disturbed mitochondrial respiration and cellular metabolism, in turn contributing to enhanced tumorigenesis and carcinogenic transformation, as well as potenti -Abstract Truncated-

Copper depletion modulates mitochondrial oxidative phosphorylation to impair triple negative breast cancer metastasis

Mitochondrial copper depletion suppresses triple-negative breast cancer in mice

Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells

Copper chelation suppresses epithelial-mesenchymal transition by inhibition of canonical and non-canonical TGF-β signaling pathways in cancer

Abstract P5-04-09: Copper Chaperons As Novel Targets for Therapy in Triple-Negative Breast Cancer (TNBC)

Mitochondrial Sulfenated-Protein-Targeted Covalent Immobilization Boosting Efficient Copper(II) Depletion for Enhanced Cancer Treatment

Copper drives remodeling of metabolic state and progression of clear cell renal cell carcinoma

COMMD3 loss drives invasive breast cancer growth by modulating copper homeostasis

Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion

Targeting copper metabolism: a promising strategy for cancer treatment

Copper depletion-induced tumor cuproptosis

Copper homeostasis and cuproptosis in tumor pathogenesis and therapeutic strategies

A copper missile-triggered power coalescence and death vortex within tumor cell mitochondria for synergistic cuproptosis/phototherapy/chemotherapy

Disulfiram/Copper Induce Ferroptosis in Triple-Negative Breast Cancer Cell Line MDA-MB-231

Regenerating Chemotherapeutics through Copper-Based Nanomedicine: Disrupting Protein Homeostasis for Enhanced Tumor Therapy

Copper-mediated novel cell death pathway in tumor cells and implications for innovative cancer therapies

Copper‐Based Composites Nanoparticles Improve Triple‐Negative Breast Cancer Treatment with Induction of Apoptosis‐Cuproptosis and Immune Activation

A copper complex that combats triple negative breast cancer by restraining angiogenesis

Finding New Molecular Targets of Two Copper(II)-Hydrazone Complexes on Triple-Negative Breast Cancer Cells Using Mass-Spectrometry-Based Quantitative Proteomics

Anti-Cancer Potency of Copper-Doped Carbon Quantum Dots Against Breast Cancer Progression